Is it time to break up with gentamicin and rifampin? 💔 Tune in to hear Drs. Sami El-Dalati, Bobbi Jo Stoner, and Jonathan Ryder, MD join Jillian Hayes on #Breakpoints to work through common controversies in the management of infective endocarditis 🫀 🎧 sidp.pinecast.co

How does a breakpoint become a breakpoint? 🧙‍♂️🧙 Drs. Jim Lewis, @MSatlin, and @jpogue1 join Erin McCreary for the answer (and more!) in the first episode of a five-episode miniseries all about #breakpoints! 🎧🪄 Listen now: sidp.pinecast.co

Cigna uses an automated system that allows “medical directors” (doctors employed by Cigna Healthcare) to deny a claim in 1.2 seconds without opening the patient’s file. Please read this, share it, and help us (metaphorically) burn these companies to the ground.

We are back with week 2 of our miniseries on #breakpoints. This week is all about Vitamin Z: piperacillin/tazobactam! Join Drs. Jim Lewis, @MSatlin, @jpogue1, and Erin McCreary for what you need to know about breakpoint updates on pip/tazo 🎧Listen now: sidp.pinecast.co

🆕 Episode of #Breakpoints! 🫁 Curious about controversies in the management of HAP/VAP? Let’s clear the air! Check out this infographic from @littlebugdrug and Justin Moore and listen along as Drs. Dahlia Blake, Owen Albin, and Ryan Rivosecchi join Erin McCreary to discuss!

Tune in for our next #Breakpoints Dosing Consult that is made for patients of all ages as we discuss antibiotic dosing in peds + adults with obesity! With Kate Kyler, MD tackling peds & Amit Pai handling adults, this is an episode you won’t want to miss! sidp.pinecast.co

🔥🔥JUST PUBLISHED 🔥🔥 IDSA 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections ESBL AmpC CRE DTR-P. aeruginosa Stenotrophomonas maltophilia CRAB #IDTwitter @pranita_tamma Sam Aitken David van Duin Neil Clancy idsociety.org/practice-guide…

🆕 Episode of #Breakpoints Drs. Snacks, PharmD, MPH, Alison Dittmer, and Michael Pulia, MD PhD join Dr. Jillian Hayes to discuss the ins and outs of #antimicrobialstewardship in one of the busiest parts of the hospital: the emergency department! 🎧 Listen now: sidp.pinecast.co

🆕 Episode of #Breakpoints In this special LIVE podcast episode, Drs. @jpogue1 and Erin McCreary present from MAD-ID The Antimicrobial Stewardship Meeting®️ and give a rundown of everything from some #ECCMID2023 late breakers to published RCTs to stewardship-focused papers 🎧 Listen now: sidp.pinecast.co

🆕 Episode of #Breakpoints: You may ❤️ it. You may hate it. You may think it’s the equivalent of doing your own taxes (hi, Adi), but this episode is all about SMX/TMP! @emilylheil & Andrew Fratoni join Jillian Hayes to unpack the data in this space 🎧 sidp.pinecast.co

The ACORN study of cefepime vs pip-tazo serves as a great lesson in how to do randomized trials in hospitalized patients. Now that we have this model, let's do more of this, please! Here's why it's so important: blogs.jwatch.org/hiv-id-observa…

🆕#Breakpoints Episode: Need help narrowing down IDWeek re-watch content? Join Drs. Erin McCreary (Erin McCreary), Julie Ann Justo (Julie Ann Justo), & Jeannette Bouchard (@jlbouchard001) to review some of the IDWeek 2023 late breaking clinical trials.🎧 sidp.pinecast.co

🆕 Episode of #Breakpoints: Time to arm yourselves with all the resources on antimicrobial locks! Join our experts, Drs. LouiseMarie Oleksiuk, nasia safdar, Joel M. Topf, MD FACP, & Julie Ann Justo to discuss lock therapy & implementation! Funding provided by CorMedix Inc 🎧 sidp.pinecast.co

Inspired by a trio of outstanding MGB Infectious Diseases Fellowship, I'm writing about the antibiotic we love to hate, and hate to love -- vancomycin. Very hard to justify it in the outpatient setting, where there are almost always safer and more convenient alternatives. blogs.jwatch.org/hiv-id-observa…

Hey insurance companies and pharmacy benefit managers and pharmacies -- requiring a prior approval and inflating the charge for a cheap generic drug makes zero sense! It's bad for patients and is unethical. Stop it already! Exhibit #1: Linezolid. blogs.jwatch.org/hiv-id-observa…

🆕#Breakpoints Episode: Drs. Chris Crnich, Angela Huttner, & @jlbouchard001 join Erin McCreary to discuss all things uUTIs! Gain insight into the new guidelines & pearls from experts. 🧫 Funding for this podcast was supported by a grant from GSK. 🎧 sidp.pinecast.co

Great work leading this Kayla Stover ! SE Research Group collaboration

🔥🔥Just published🔥🔥 Our NEW WikiGuidelines JAMA Network Open A stellar cast of auth🌟rs Snacks, PharmD, MPH Alfredo J Mena Lora MD FIDSA Brad Spellberg Todd C. Lee Emily McDonald Guidelines for the Prevention Diagnosis,and Management of Urinary Tract Infections in Pediatrics& Adults jamanetwork.com/journals/jaman…

✨New #SIDP #Breakpoints episode out today🎙️🎧 #IDTwitter #TwitteRx Hear how experts turned a clindamycin shortage & other opportunities into modernizing abx for OB-Gyn infxns. 🍋➡️🥤 Thx to Drs. Pam Bailey, Ben Ereshefsky, & Amy Crockett! 🔗: sidp.pinecast.co

Posting for a colleague who isn’t on X. Patient with PMH NSC lung cancer presented with AMS and UTI. Was initially started on meropenem for hx of ESBL E. coli 3 months ago and improved. Developed 2 of 2 sets of positive bld cx with NDM gene Brad Spellberg Zayd Ahmad, PharmD, BCIDP